Reporter Tag Knock-in

Precise knock-in of reporter genes at endogenous loci using CRISPR/Cas9 enables real-time quantitative monitoring of gene expression and signaling pathway analysis.Compared to transient transfection or random integration systems, Reporter Tag Knock-in offers stable expression (single-copy integration), low background signal, and high data reproducibility.Based on the FLASH-KI™ technology platform, we achieve efficient co-delivery of Cas9 RNP and Donor templates, improving knock-in efficiency and stability while maintaining ≥90% cell viability.

Service Details

Cell Types Wide range including tumor cell lines, normal somatic cell lines, stem cells, etc.
Services Reporter Tag knock-in (Luciferase Firefly/Renilla, HiBiT, etc.), high-throughput screening model construction
Deliverables 1 monoclonal cell line + parental cell line (2 vials/cell line, 1×10^6 cells/vial)
Turnaround / Price   Consult online for details

Why Choose Our Knock-in Tag Service?

Core Performance Metrics
Metric Value
Knock-in efficiency 45%–88%
Cell viability ≥90%
Project success rate 83%
Completed Projects 100+

Service Advantages

Stable expression system
Single-copy integration
Long-term stable expression
Quantitative analysis capability
Real-time dynamic monitoring
Suitable for automated platforms
High-sensitivity detection
Luciferase / HiBiT systems
Low background, high signal-to-noise ratio
FLASH-KI™ Efficient Delivery
No electroporation/viral vectors required
RNP + Donor co-delivery
Suitable for hard-to-transfect cells

Tag Types and Applications

Tags Luciferase (Firefly/Renilla), HiBiT
Insertion position 3'UTR or ORF
Applications Signaling pathway analysis, high-throughput screening, in vivo imaging, promoter activity assays, gene expression tracking
Features High sensitivity, quantifiable, suitable for automated platforms

Workflow

 

Case Study

Goal: Luciferase reporter knock-in at the CHO-K1 safe harbor locus for long-term in vivo bioluminescence tracing.
Approach: FLASH-KI™ delivery of Cas9 RNP + Donor vector containing Luciferase.
Result: Single-copy site-specific integration clone obtained; high and stable luminescence in vitro; used by customer for biodistribution studies of cell therapy products.
Sample Replicate 1 Replicate 2 Replicate 3 Mean Expression Fold
WT 750 978 1402 1043 226

Advantage and Characteristic

Optimazied Strategy
We have create a unique sgRNA Design Logic
Optimazied Strategy
We have create a unique sgRNA Design Logic
Optimazied Strategy
We have create a unique sgRNA Design Logic
Optimazied Strategy
We have create a unique sgRNA Design Logic

FAQ

Yes, Dual-luciferase designs are supported.
Stable expression
high data consistency
suitable for long-term experiments
Yes, supports bioluminescence imaging.
Yes, suitable for automated screening platforms.

Contact Us

*
*
*
*
How did you hear about us:
Contact Us
*
*
*
*
How did you hear about us: